How peptides are tested: HPLC, mass spec and reading a COA
What HPLC purity, mass spectrometry and peptide content each measure, what a certificate of analysis should show, and the warning signs in one.
A Certificate of Analysis (COA) is the primary quality-assurance record for any synthetic peptide. Knowing how to interpret its core analytical metrics ensures that experimental data reflects the true activity of the target molecule rather than synthesis artifacts.
1. Reversed-Phase HPLC (Purity Percentage)
High-Performance Liquid Chromatography separates components in a sample based on hydrophobicity as they pass through a C18 stationary phase column. The resulting chromatogram displays UV absorbance (typically at 214 nm or 220 nm) over retention time. HPLC purity represents the area under the main target peak expressed as a percentage of the total integrated peak area. A clean trace shows a single sharp, symmetrical dominant peak (≥98%) with minimal flanking shoulder peaks.
2. Mass Spectrometry (Identity Verification)
While HPLC confirms homogeneity, it does not prove what the molecule is. Electrospray Ionization Mass Spectrometry (ESI-MS) ionizes the peptide and measures its mass-to-charge ratio (m/z). Researchers verify identity by confirming that the observed multiply-charged ion peaks (e.g., [M+2H]2+ or [M+3H]3+) correspond precisely to the theoretical molecular weight of the sequence.
3. Net Peptide Content vs. HPLC Purity
A crucial distinction in quantitative biochemistry is that HPLC purity is not net peptide content. Lyophilised peptides naturally retain bound water molecules and counter-ions (such as acetate or trifluoroacetate salts). Therefore, a vial containing 15mg gross weight at 99% HPLC purity typically yields a net peptide content of 75% to 85% by mass—a factor that must be accounted for when preparing precise molar stock solutions.